Skip to content

REduction of Airborne PArticulates In the SuRgical Field Using the SURGITENT Extremity during Upper Extremity Surgery

REduction of Airborne PArticulates In the SuRgical Field Using the SURGITENT Extremity during Upper Extremity Surgery - REPAIR

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00036591
Enrollment
12
Registered
2025-04-09
Start date
2025-04-29
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M72.0

Interventions

Group 1: Assessment of the air quality inside the Surgitent Extremity throughout Dupuytren surgeries by measurement of number and size of airborne particulates (particulate count per m3 in total and i

Sponsors

Surgitent GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: o Male/ Female/ Divers o Indication for surgical treatment of the above-named conditions using the SURGITENT Extremity o Written informed consent o Age =18 years

Exclusion criteria

Exclusion criteria: o Inability of the patient to consent/ lack of ability to report any side effects (e.g., presence of severe cognitive deficits) o Emergency setting o Presence of terminal disease with a life expectancy =6 months o Presence of skin disease(s) and/ or malignant lesion(s) of the skin in the anticipated extended surgical area o Malformations and/or fractures that hamper positioning of the arm before/ during surgery and thus use of the SURGITENT Extremity as intended o Intake of Vitamin K antagonists and/ or new oral anticoagulant medication, which may prolong surgery duration and/or complicate surgery execution o Contraindications to the SURGITENT Extremity according to the instructions for use (IFU) o Participation in another study o Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
oAssessment of the air quality inside the SURGITENT Extremity throughout upper extremity surgery a)Acquisition of number and size of airborne particulates (particulate count per m3 in total and in the size groups = 0.5µm and < 0.5µm) inside the sterile field

Secondary

MeasureTime frame
o Assessment of post-operative infection o Usability assessment of the SURGITENT Extremity (questionnaire to be answered by surgeon and/ or nurse) a) Installation of the SURGITENT b) Usability of the SURGITENT including parameters such as visibility

Countries

Germany

Contacts

Public ContactDominik Steiner

BG Unfallklinik

DSteiner@bgu-tuebingen.de+4970716061038

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026